Variation in M. tuberculosis in response to host selection
Variation in M. tuberculosis in response to host selection
批准号:
7932340
负责人:
SARAH FORTUNE
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2012-08-31
关键词:
AcuteAddressAdenineAerosolsAffectAlgorithmsAllelesAnimal ModelAnimalsAntibioticsAntibodiesAntigen-Presenting CellsAntigensArchitectureAscaridilAttenuatedAutomationAutomobile DrivingBacteriaBacterial AntigensBacterial ChromosomesBacterial GenesBacterial InfectionsBacterial RNABase PairingBiologyBlood capillariesCD8B1 geneCandidate Disease GeneCarrier ProteinsCell physiologyCellsCessation of lifeCharacteristicsChemistryChromosomesChronicClinicalClonalityCollaborationsColorComplementComplexComputer softwareComputersCongenic StrainCoupledCytosineCytosolDNADNA DamageDNA MethylationDNA RepairDNA ResequencingDNA Restriction EnzymesDNA Sequence RearrangementDam methyltransferaseDataDetectionDevelopmentDideoxy Chain Termination DNA SequencingDiseaseDisease modelElementsEngineeringEnvironmentEnzymesEpigenetic ProcessEpitopesEquipmentEscherichia coliEssential GenesEukaryotaEukaryotic CellEventExperimental ModelsFamilyFortuneFoundationsFreezingFrequenciesFunding MechanismsFutureGene ExpressionGene Expression RegulationGene FamilyGene FrequencyGene MutationGene StructureGenerationsGenesGeneticGenetic PolymorphismGenetic RecombinationGenetic ScreeningGenetic VariationGenetsGenomeGenomicsGenus MycobacteriumGoalsGrowthGuanineHIVHaplotypesHeartHeterogeneityHoloenzymesHorizontal Gene TransferHourHumanHypoxiaImmuneImmune responseImmune systemImmunityImmunocompromised HostIn VitroInbred C3H MiceIncubatedIndividualInfectionInfection ControlInheritance PatternsInstitutesIntegration Host FactorsInterferonsIsotopesLabelLaboratoriesLacZ GenesLengthLibrariesLifeLiteratureLungMacacaMapsMass Spectrum AnalysisMassachusettsMeasurableMeasuresMediatingMediator of activation proteinMembrane ProteinsMethodologyMethodsMethylationMethyltransferaseMicroarray AnalysisMinorModelingModificationMolecularMolecular ProfilingMorphologyMusMutateMutationMycobacterium bovisMycobacterium smegmatisMycobacterium tuberculosisNatureNucleic AcidsOligonucleotide MicroarraysOrganOrganismParentsPathogenesisPatternPeptidesPersonal CommunicationPharmaceutical PreparationsPhasePhenotypePilot ProjectsPilumPlanet MarsPlasmidsPlayPolymorphism AnalysisPopulationPriceProcessProkaryotic CellsProtein SecretionProteinsProteobacteriaProteomeProteomicsProtocols documentationPublishingPyelonephritisReadingRegulationRegulonRelative (related person)ReporterResearchResearch PersonnelRoleRouteRunningSamplingScientistSequence AnalysisSingle Nucleotide PolymorphismSiteSorting - Cell MovementSpeedStressStructureStructure of parenchyma of lungSurfaceSurface AntigensSystemT-LymphocyteT-Lymphocyte EpitopesTechnologyTestingTimeTuberculosisUniversitiesUropathogenic E. coliVaccinesVariantVirulenceVirulence FactorsVirulentWorkabstractingbacterial geneticsbasecapillarycell typecostdesigndesign and constructionepigenetic variationexperienceexpression vectorfallsgene functiongenome sequencinghomologous recombinationin vivoinnovationinnovative technologiesinorganic phosphateinsertion/deletion mutationinsightinterestlatent infectionmacrophagemedical schoolsmicrobialmouse modelmutantmycobacterialnew technologynovelnovel vaccinespathogenpressurepromoterprotein functionresearch studyresponseskillssuccesstandem mass spectrometrytherapeutic vaccinetrendvaccine developmentvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
07-ABSTRACT
All pathogens that cause chronic infections must avoid clearance by the host immune
response. Many have complex mechanisms to rapidly generate diversity in critical antigens.
Mycobacterium tuberculosis chronically infects one third of the worlds' population and
similarly must avoid clearance by the host immune system. However, there is currently little
understanding of whether M. tuberculosis, like so many other pathogens, diversifies in vivo to
escape host immune selection. In this proposal, we will test the hypothesis that M.
tuberculosis varies, either genetically or epigenetically, during the course of infection and that
this variation contributes to the ability of the bacteria to avoid clearance by the host immune
response. We will use new genomics technologies¿low cost genome sequencing and
expression profiling¿to systematically assess genetic and epigenetic variation in bacteria
selected in a simple experimental model of disease chosen to create different immune
pressures on the bacteria ¿mice of different MHC haplotypes. In these studies, we expect
to provide fundamental insights into the mechanisms and targets of diversifying immune
selection in M. tuberculosis.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.jmb.2014.06.013
发表时间:
2015-03-13
期刊:
JOURNAL OF MOLECULAR BIOLOGY
影响因子:
5.6
作者:
[Ramsdell, Talia L., Huppert, Laura A., Sysoeva, Tatyana A., Fortune, Sarah M., Burton, Briana M.]
通讯作者:
Burton, Briana M.
Establishing the Genetic Basis of Altered Drug Responses in Mycobacterium tuberculosis
-
批准号:10595538
-
项目类别:
-
资助金额:$164.79万
-
财政年份:2019
-
负责人:SARAH FORTUNE
-
依托单位:
Establishing the Genetic Basis of Altered Drug Responses in Mycobacterium tuberculosis
-
批准号:10390301
-
项目类别:
-
资助金额:$99.03万
-
财政年份:2019
-
负责人:SARAH FORTUNE
-
依托单位:
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
-
批准号:10027082
-
项目类别:
-
资助金额:$1064.75万
-
财政年份:2019
-
负责人:SARAH FORTUNE
-
依托单位:
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
-
批准号:10925119
-
项目类别:
-
资助金额:$874.28万
-
财政年份:2019
-
负责人:SARAH FORTUNE
-
依托单位:
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
-
批准号:10252739
-
项目类别:
-
资助金额:$819.12万
-
财政年份:2019
-
负责人:SARAH FORTUNE
-
依托单位:
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
-
批准号:10691842
-
项目类别:
-
资助金额:$925.28万
-
财政年份:2019
-
负责人:SARAH FORTUNE
-
依托单位:
Bacterial Determinants of Tuberculosis Susceptibiliy
-
批准号:10219088
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2017
-
负责人:SARAH FORTUNE
-
依托单位:
The Consequences of Reinfection with M. tuberculosis
-
批准号:9096704
-
项目类别:
-
资助金额:$76.54万
-
财政年份:2015
-
负责人:SARAH FORTUNE
-
依托单位:
PE and PPE Function
-
批准号:7258173
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2007
-
负责人:SARAH FORTUNE
-
依托单位:
PE and PPE Function
-
批准号:7500066
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2007
-
负责人:SARAH FORTUNE
-
依托单位:
Variation in M. tuberculosis in response to host selection
-
批准号:7426989
-
项目类别:
-
资助金额:$244.98万
-
财政年份:2007
-
负责人:SARAH FORTUNE
-
依托单位:
M tuberculosis evasion of the innate immune response
-
批准号:6418605
-
项目类别:
-
资助金额:$11.15万
-
财政年份:2002
-
负责人:SARAH FORTUNE
-
依托单位:
M tuberculosis evasion of the innate immune response
-
批准号:6893977
-
项目类别:
-
资助金额:$12.23万
-
财政年份:2002
-
负责人:SARAH FORTUNE
-
依托单位:
M tuberculosis evasion of the innate immune response
-
批准号:6749030
-
项目类别:
-
资助金额:$12.23万
-
财政年份:2002
-
负责人:SARAH FORTUNE
-
依托单位:
M tuberculosis evasion of the innate immune response
-
批准号:6644103
-
项目类别:
-
资助金额:$12.23万
-
财政年份:2002
-
负责人:SARAH FORTUNE
-
依托单位:
Bacterial Determinants of Tuberculosis Susceptibiliy
-
批准号:9751738
-
项目类别:
-
资助金额:$43.24万
-
财政年份:--
-
负责人:SARAH FORTUNE
-
依托单位:
Develomental Core
-
批准号:9527736
-
项目类别:
-
资助金额:$63.17万
-
财政年份:--
-
负责人:SARAH FORTUNE
-
依托单位:
Develomental Core
-
批准号:8883325
-
项目类别:
-
资助金额:$66.34万
-
财政年份:--
-
负责人:SARAH FORTUNE
-
依托单位:
Establishing the Genetic Basis of Altered Drug Responses in Mycobacterium tuberculosis
-
批准号:9918261
-
项目类别:
-
资助金额:$75.77万
-
财政年份:--
-
负责人:SARAH FORTUNE
-
依托单位:
Bacterial Determinants of Tuberculosis Susceptibiliy
-
批准号:9359034
-
项目类别:
-
资助金额:$42.09万
-
财政年份:--
-
负责人:SARAH FORTUNE
-
依托单位:
海外基金